4 Results for "

PUGNAc

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PUGNAc" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-108241
CAS No.: 132489-69-1
Purity:  99.13%
Target:  

OGA

Research Areas:  

Metabolic Disease

(Z)-PUGNAc is a potent O-GlcNAcase inhibitor. (Z)-PUGNAc is a vastly more potent inhibitor of O-GlcNAcase than the E form .
loading...
    loading...
Cat. No.: HY-108241R
CAS No.: 132489-69-1
Target:  

OGA Reference Standards

Research Areas:  

Metabolic Disease

(Z)-PUGNAc (Standard) is the analytical standard of (Z)-PUGNAc (HY-108241). This product is intended for research and analytical applications. (Z)-PUGNAc is a potent O-GlcNAcase inhibitor. (Z)-PUGNAc is a vastly more potent inhibitor of O-GlcNAcase than the E form .
loading...
    loading...
Cat. No.: HY-108241A
CAS No.: 1145878-98-3
Target:  

Glycosidase

Research Areas:  

Neurological Disease

Galacto-PUGNAc is a selective competitive inhibitor of lysosomal β-hexosaminidases (HEX), with Ki values of 51 and 18 nM, for hHEXA and hHEXB, respectively. Galacto-PUGNAc elevates GM2 ganglioside levels in neuroblastoma cells. Galacto-PUGNAc can be used for the research of neurodegenerative disorders .
loading...
    loading...
Cat. No.: HY-E71360
Target:  

Glycosidase

Research Areas:  

Others

O-GlcNAcase, Clostridium perfringens is a glycosidase derived from Clostridium perfringens, which functions in bacterial nutrient metabolism, host interaction and virulence regulation. O-GlcNAcase is a core enzyme in the cellular signal regulatory network and serves as a key target for various major and chronic diseases. O-GlcNAcase, Clostridium perfringens can be used for basic research and drug development of O-GlcNAcase due to its high conservation in catalytic mechanism and structure with human-derived enzymes .
loading...
    loading...